Log In
Sign Up
Hemophilia A and von Willebrand's Disease (Type I), diabetes Insipidus, bedwetting
Hemophilia A and von Willebrand's Disease (Type I): DDAVP Injection 4 mcg/mL is administered as an intravenous infusion at a dose of 0.3 mcg DDAVP/kg body weight diluted in sterile physiological saline and infused slowly over 15 to 30 minutes. In adults and children weighing more than 10 kg, 50 mL of diluent is recommended; in children weighing 10 kg or less, 10 mL of diluent is recommended. Diabetes Insipidus: administered sc or IV: 4 mcg/mL dosage must be determined for each patient and adjusted according to the pattern of response. Response should be estimated by two parameters: adequate duration of sleep and adequate, not excessive, water turnover.The usual dosage range in adults is 0.5 mL (2.0 mcg) to 1mL (4.0 mcg) daily, usually in two divided doses.
Mode of action
Side Effects
Pregnancy risk
Special information
Brands containing this Ingredient
Name Form. Strength Pack Price Insert Manufacturer Distributor
Minirin. tabs 0.1mg 30 KES3,663.00
Minirin. tabs 0.2mg 30 KES5,300.00
Minirin. Melt tabs 60mcg 30 KES5,000.00
Minirin. Melt tabs 120mcg 30 KES10,000.00
Drug Index 2.0 is here
Our new update features a more powerful search feature and easier login. Having any issues? Contact us today. Contact Us